NCI Press Release June 4, 2018 The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has achieved a milestone with the release […]
The term nanomedicine, alluding to technologies with mechanisms and surface area characteristics sized in terms of billionths of a meter, has held promise for years, but breakthroughs specific to therapies have been […]
ROCKVILLE, MD – Researchers from Wake Forest Baptist Medical Center and Tianjin Medical University Cancer Institute and Hospital (TMUCIH) have discovered that gastric cancer tissue samples bearing mutation of a specific gene, […]
In a major breakthrough, scientists led by Elena Deryugina at The Scripps Research Institute (TSRI) identified a specific protein, Latent TGFβ Binding Protein 3—LTBP3 for short—that kicks off a cellular chain reaction […]
Greg Simon is the president of the Biden Cancer Initiative, formerly called The Cancer Moonshot, the goal was to try to make ten years of progress in five years. It was kicked […]
The Cancer Investor Conference October 30th & 31st to Unveil Global Cancer Database for Investors NEW YORK – Altru Institute, organizer of the Global Cancer Consortium, has announced that a global […]
Two days of exceptional programming and networking anchored by 28 oncology companies. Attending investors heard insights from Jack Hidary Google Artificial Intelligence strategist provided insight on the future role of AI treating Cancer. Dr. […]
Cervical Cancer Cervical cancer continues to affect women of all ages worldwide. The disease often presents no symptoms in its early stages, which is why it is often referred to as a […]
